A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/34 (2006.01) A61K 31/519 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01)
Patent
CA 2687979
The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
L'invention concerne un système d'administration à libération prolongée de rispéridone pour le traitement d'états médicaux en rapport avec la psychose délirante, la schizophrénie, les troubles bipolaires, la dépression psychotique, les troubles obsessionnels compulsifs, le syndrome de Gilles de la Tourette, et les troubles du spectre autistique. Le système d'administration à libération prolongée comprend une composition liquide contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci et un implant contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci. La composition liquide peut être injectée dans le tissu où il coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comprend un polymère thermoplastique biodégradable, un liquide organique et de la rispéridone, un métabolite, ou un promédicament de celle-ci.
Goudreau Gage Dubuc
Tolmar Therapeutics Inc.
LandOfFree
Sustained delivery formulations of risperidone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained delivery formulations of risperidone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained delivery formulations of risperidone compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1929488